Integer (NYSE:ITGR) Releases Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Integer (NYSE:ITGR) posted its quarterly earnings results on Thursday. The medical equipment provider reported $1.43 EPS for the quarter, missing the consensus estimate of $1.46 by ($0.03), Zacks reports. Integer had a return on equity of 11.63% and a net margin of 6.70%. Integer updated its FY 2025 guidance to 5.840-6.200 EPS.

Integer Stock Down 2.8 %

Shares of Integer stock traded down $3.95 on Thursday, reaching $139.26. 222,791 shares of the company were exchanged, compared to its average volume of 228,729. Integer has a 1-year low of $97.49 and a 1-year high of $146.36. The company has a market cap of $4.67 billion, a P/E ratio of 43.25, a price-to-earnings-growth ratio of 1.80 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. The stock’s 50 day moving average price is $137.98 and its 200-day moving average price is $132.28.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. KeyCorp boosted their price objective on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Piper Sandler restated an “overweight” rating and issued a $140.00 price objective (up from $125.00) on shares of Integer in a report on Friday, October 25th. Wells Fargo & Company restated an “overweight” rating and issued a $160.00 price objective on shares of Integer in a report on Tuesday, December 3rd. Truist Financial boosted their price objective on shares of Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Finally, Citigroup boosted their price target on shares of Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Integer has an average rating of “Moderate Buy” and an average target price of $146.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.